What are the benefits of a tracheostomy?

Benefits of Tracheostomy

Tracheostomy should be considered when prolonged mechanical ventilation (>10-15 days) is anticipated, as it offers multiple clinical advantages including reduced sedation requirements, improved patient comfort, shorter ICU stays, and potentially fewer ventilator-free days, though mortality benefits remain unclear. 1

Primary Clinical Benefits

Ventilation and Weaning Advantages

• Facilitates weaning from mechanical ventilation by reducing work of breathing and dead space 2
• Increases ventilator-free days compared to prolonged endotracheal intubation 1
• Enables earlier liberation from mechanical ventilation - studies show 33% of patients were successfully weaned at mean follow-up 1
• Allows easier disconnection from the ventilator for progressive mobilization 2

ICU and Hospital Length of Stay

• Reduces ICU length of stay - multiple studies demonstrate shorter ICU duration with early tracheostomy 1
• Decreases overall hospital stay compared to prolonged intubation 1
• Facilitates earlier transfer to regular ward - patients with tracheostomy transferred after 4.7 days versus 6.9 days for intubated patients 3

Sedation and Patient Comfort

• Significantly reduces sedation requirements, allowing patients to be more alert and interactive 1
• Increases sedation-free days compared to prolonged endotracheal intubation 1
• Improves patient comfort through reduced pharyngolaryngeal irritation 4
• Decreases incidence of postoperative delirium - only 9.5% with tracheostomy versus 30.8% with endotracheal tube 3

Airway Management Benefits

Secretion Management and Airway Protection

• Provides superior airway clearance and easier suctioning of respiratory secretions 5, 4
• Facilitates buccopharyngeal hygiene and oral care 4
• Enables airway protection in patients with compromised protective reflexes 5

Procedural Advantages

• Allows simpler reinsertion if accidental decannulation occurs compared to emergency reintubation 4
• Reduces risk of accidental extubation - early tracheostomy groups show fewer accidental extubations 1
• Decreases pharyngolaryngeal trauma from prolonged endotracheal intubation 4

Infectious Complications

Ventilator-Associated Pneumonia (VAP)

The evidence on VAP reduction is mixed and remains controversial 1:

• Some studies show reduced VAP incidence - particularly with early tracheostomy and in large retrospective analyses of 125,000 cases 1
• Other studies, including a 2015 Cochrane review of 2,000 patients, found no difference in VAP rates 1
• May reduce hospital-acquired pneumonia - only 2.1% pneumonia rate with tracheostomy versus 10.6% with intubation in head/neck surgery patients 3
• Decreased sepsis rates associated with early tracheostomy in large retrospective studies 1

Quality of Life Benefits

Communication and Functionality

• Enables earlier phonation and speech through use of speaking valves 6, 2
• Facilitates oral communication improving patient interaction with family and healthcare team 4, 7
• Allows maintenance of swallowing function and potential for oral intake 4
• Improves olfaction which can positively impact eating 6

Mobility and Rehabilitation

• Permits earlier mobilization of critically ill patients 2
• Facilitates nursing care and patient handling 4
• Enables possible glottic closure for physiologic benefits 4

Specific Clinical Indications

Tracheostomy is performed for several key indications 5:

• Management of upper airway obstruction
• Long-term ventilation requirements
• Assistance with secretion removal in patients with impaired clearance
• Facilitation of weaning in anticipated prolonged ventilation

Mortality Considerations

The mortality benefit of tracheostomy remains unclear and controversial 1:

• A 2015 Cochrane systematic review of 8 RCTs with nearly 2,000 participants showed lower mortality with early tracheostomy (NNT approximately 11) 1
• Multiple other prospective randomized studies found no statistically significant difference in 30-day, 60-day, or 2-year mortality 1
• Large-scale database examination suggests potential mortality benefit in general ICU patients, with more pronounced benefits in neurosurgical and COVID-19 populations 8

Cost and Resource Benefits

• Reduces hospital costs through shorter ICU stays and decreased sedation use 4
• Bedside tracheostomy offers 73.1% cost reduction compared to operating room procedures 9
• Optimizes ICU resource utilization particularly important during resource-constrained situations 1
• Decreases operative time when performed at bedside versus operating room 9

Important Caveats

Timing Considerations

• Optimal timing remains debatable - conventional practice is 2-3 weeks after intubation, but evidence supports consideration at 10-15 days 1
• Risk of unnecessary procedures - in one large multicenter trial, 55% of patients randomized to late tracheostomy never required the procedure 1
• Patient selection is critical to avoid performing tracheostomy on patients who may successfully extubate 1

Complications to Consider

Tracheostomy carries procedural risks 5, 4:

• Immediate complications: hemorrhage, loss of airway
• Short-term complications: tube blockage, displacement
• Long-term complications: tracheomalacia, tracheal stenosis, stomal problems

Evidence Limitations

• Most evidence is from heterogeneous populations including medical ICU, surgical ICU, and COVID-19 patients 1, 8
• Specific populations (neurosurgical, COVID-19) show more pronounced benefits than general ICU patients 8
• Prediction of ventilation duration remains challenging, making timing decisions difficult 4